Mennear J H, Schonwalder C, Yau E T
Diabetologia. 1976 Jul;12(3):263-7. doi: 10.1007/BF00422094.
The effects of barbituric acid and phenobarbital upon carbohydrate metabolism in mice were compared. An intraperitoneal dose of 100 mg/kg of barbituric acid increased blood glucose concentrations during an intravenous glucose tolerance test, but did not alter the rate of glucose disappearance from the blood. Barbituric acid also antagonized the hypoglycemic effect of intravenously administered tolbutamide. The same dose of phenobarbital had no effect. An in vitro concentration of 100 mug/ml of barbituric acid decreased the responsiveness of isolated mouse pancreatic islets to glucose stimulation (3.0 mg/ml D-glucose). Again phenobarbital, 100 mug/ml, was without effect. The structural similarities between barbituric acid, tolbutamide and alloxan suggest that the effects observed in these experiments might reflect a competition for binding to reactive sites on or within the pancreatic B-cell.
比较了巴比妥酸和苯巴比妥对小鼠碳水化合物代谢的影响。在静脉葡萄糖耐量试验期间,腹腔注射100mg/kg的巴比妥酸可提高血糖浓度,但不会改变血糖从血液中消失的速率。巴比妥酸还拮抗静脉注射甲苯磺丁脲的降血糖作用。相同剂量的苯巴比妥则无此作用。体外浓度为100μg/ml的巴比妥酸可降低分离的小鼠胰岛对葡萄糖刺激(3.0mg/ml D-葡萄糖)的反应性。同样,100μg/ml的苯巴比妥也无作用。巴比妥酸、甲苯磺丁脲和四氧嘧啶之间的结构相似性表明,在这些实验中观察到的效应可能反映了它们竞争与胰腺β细胞上或细胞内的反应位点结合。